pharma news today obesity drugs glp-1 october 2025 health Outlook for obesity in 2025: more Obesity drugs could fuel the
Description
Enjoy a non-invasive, daily dose solution without injections for convenient weight management.
Learn why some patients cannot tolerate these medications and when endoscopic sleeve may be considered.
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
Our physician-led medical spa ensures you receive FDA-approved GLP-1 medications and answers 10 FAQs.
Tirzepatide was more efficacious in reducing body weight
Four weeks ago, I wrote about my decision to undertake a weight-loss journey using a GLP-1 (a semagl
